As regenerative medicine continues to evolve, healthcare providers are increasingly adopting the EMTT-Shockwave combined approach to improve patient outcomes and expand treatment capabilities.
But successful integration requires more than access to technology; it requires clinical insight and real-world application strategies.
In an educational webinar from our ongoing series, Dr. Brice Blatz, MD, covers this topic in detail and shares how he integrates Extracorporeal Shockwave Therapy (ESWT/EPAT®) and Extracorporeal Magnetotransduction Therapy (EMTT®) into his regenerative medicine practice.
This blog highlights key takeaways from that engaging, informative session and how providers can apply them.
In his regenerative medicine practice, Dr. Blatz utilizes the EMTT-Shockwave combined approach across a wide spectrum of musculoskeletal (MSK) conditions.
His approach is grounded in leveraging the complementary effects of each modality:
As Dr. Blatz explains, these technologies work together to help “re-educate” dysfunctional tissue and improve healing at multiple levels.
According to Dr. Blatz, the EMTT-Shockwave combined approach is highly versatile and effective across:
His experience highlights how combining modalities can expand treatment options for both acute and chronic presentations and deliver accelerated, optimized healing outcomes.
Providers using this approach commonly observe:
Clinical Insight from Dr. Blatz
“When you combine these technologies, you’re not just treating pain, you’re influencing the tissue environment in a meaningful way.”
This dual-level effect is a key advantage of the EMTT-Shockwave combined approach.
Beyond clinical outcomes, Dr. Blatz highlights the impact on practice performance and growth.
Practices implementing this approach often see:
A key theme in Dr. Blatz’s clinical approach is that technology alone does not determine outcomes; implementation does.
Core Integration Principles
These fundamentals help ensure consistency, efficiency, and optimal clinical results.
To further support your understanding, explore these related insights:
Ideal candidates are patients with chronic tendinopathy/enthesopathy, persistent myofascial pain, degenerative joint pain, or delayed recovery who have not fully responded to standard conservative care. Best results are typically seen when therapy is paired with diagnosis-specific rehab and load management.
Most patients experience gradual improvement over the course of care, with early changes often seen in pain and tissue sensitivity, followed by functional gains. Outcomes vary based on chronicity, tissue quality, and adherence to rehab, but combination therapy is commonly used to support more consistent and sustained progress.
Many clinicians start with a short series (often 3–6 sessions) and re-evaluate after 2–3 visits for pain, function, and tissue tolerance. Treatments may be delivered same-day or alternating visits, then tapered or progressed based on response and goals.
Many practices use EMTT-Shockwave to help patients tolerate progressive loading and to support tissue conditioning pre- and post-procedure. When combined with injections or orthobiologics, clinicians typically coordinate timing around symptom flare windows and rehab phases to keep the overall plan coherent.
Clinicians typically combine these modalities based on tissue type, depth, and treatment goals. Shockwave therapy is often used to provide targeted mechanical stimulation, while EMTT® supports the broader tissue environment, including bone and inflammatory processes. Many providers sequence or co-apply both within the same plan to reinforce treatment effects and support progression.
Most patients experience gradual improvement over the course of care, with early changes often seen in pain and tissue sensitivity, followed by functional gains. Outcomes vary based on chronicity, tissue quality, and adherence to rehab, but combination therapy is commonly used to support more consistent and sustained progress.
To see how this approach is applied in real-world practice, watch the full session:
In this webinar, Dr. Blatz covers:
CuraMedix supports providers with:
Reach out, and we’ll connect you with an expert on our team who truly understands the best solution for your clinical practice needs.
Dr. Brice Blatz, MD, is a double board-certified in Family and Sports Medicine physician and founder of Maple Medical. He specializes in integrating advanced, non-invasive technologies, including Shockwave therapy and EMTT with orthobiologics to support tissue healing, restore function, and improve patient outcomes. His clinical expertise provides practical insight into how combination therapies can be successfully implemented in modern regenerative medicine practices.